Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction.

Circ Genom Precis Med

Center for Individualized and Genomic Medicine Research (CIGMA) (H.G., J. Luzum, T.D.B., K.W., D.E.L.), Henry Ford Hospital.

Published: June 2021

Background: It remains unclear whether the plasma proteome adds value to established predictors in heart failure (HF) with reduced ejection fraction (HFrEF). We sought to derive and validate a plasma proteomic risk score (PRS) for survival in patients with HFrEF (HFrEF-PRS).

Methods: Patients meeting Framingham criteria for HF with EF<50% were enrolled (N=1017) and plasma underwent SOMAscan profiling (4453 targets). Patients were randomly divided 2:1 into derivation and validation cohorts. The HFrEF-PRS was derived using Cox regression of all-cause mortality adjusted for clinical score and NT-proBNP (N-terminal pro-B-type natriuretic peptide), then was tested in the validation cohort. Risk stratification improvement was evaluated by C statistic, integrated discrimination index, continuous net reclassification index, and median improvement in risk score for 1-year and 3-year mortality.

Results: Participants' mean age was 68 years, 48% identified as Black, 35% were female, and 296 deaths occurred. In derivation (n=681), 128 proteins associated with mortality, 8 comprising the optimized HFrEF-PRS. In validation (n=336) the HFrEF-PRS associated with mortality (hazard ratio, 2.27 [95% CI, 1.84-2.82], =6.3×10), Kaplan-Meier curves differed significantly between HFrEF-PRS quartiles (=2.2×10), and it remained significant after adjustment for clinical score and NT-proBNP (hazard ratio, 1.37 [95% CI, 1.05-1.79], =0.021). The HFrEF-PRS improved metrics of risk stratification (C statistic change, 0.009, =0.612; integrated discrimination index, 0.041, =0.010; net reclassification index=0.391, =0.078; median improvement in risk score=0.039, =0.016) and associated with cardiovascular death and HF phenotypes (eg, 6-minute walk distance, EF change). Most HFrEF-PRS proteins had little known connection to HFrEF.

Conclusions: A plasma multiprotein score improved risk stratification in patients with HFrEF and identified novel candidates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221080PMC
http://dx.doi.org/10.1161/CIRCGEN.120.003140DOI Listing

Publication Analysis

Top Keywords

plasma proteomic
8
heart failure
8
failure reduced
8
reduced ejection
8
ejection fraction
8
proteomic profile
4
profile predicts
4
predicts survival
4
survival heart
4
fraction background
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!